Literature DB >> 29731116

National Landscape of Unplanned 30-Day Readmissions in Patients With Left Ventricular Assist Device Implantation.

Shanti Patel1, Priti Poojary2, Sumeet Pawar3, Aparna Saha2, Achint Patel4, Kinsuk Chauhan2, Ashish Correa5, Pratik Mondal6, Kanika Mahajan2, Lili Chan2, Rocco Ferrandino2, Dhruv Mehta6, Shiv Kumar Agarwal4, Narender Annapureddy7, Jignesh Patel8, Paul Saunders9, Gregory Crooke9, Jacob Shani10, Tariq Ahmad11, Nihar Desai12, Girish N Nadkarni2, Vijay Shetty10.   

Abstract

The number of patients with advanced heart failure receiving left ventricular assist device (LVAD) implantation has increased dramatically over the last decade. There are limited data available about the nationwide trends of complications leading to readmissions after implantation of contemporary devices. Patients who underwent LVAD implantation from January 2013 to December 2013 were identified using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) code 37.66 from the Healthcare Cost and Utilization Project's National Readmission Database. The top causes of unplanned 30-day readmission after LVAD implantation were determined. Survey logistic regression was used to analyze the significant predictors of readmission. In 2013, there were 2,235 patients with an LVAD implantation. Of them, 665 (29.7%) had at least 1 unplanned readmission within 30 days, out of which 289 (43.4%) occurred within 10 days after discharge. Implant complications (14.9%), congestive heart failure (11.7%), and gastrointestinal bleeding (8.4%) were the top 3 diagnoses for the first readmission and accounted for more than a third of all readmissions. Significant predictors of readmissions included a prolonged length of stay during the index admission, Medicare insurance, and discharge to short-term facility. In conclusion, despite increased experience with LVADs, unplanned readmissions within 30 days of implantation remain significantly high.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29731116      PMCID: PMC7818514          DOI: 10.1016/j.amjcard.2018.03.363

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.

Authors:  Joseph G Rogers; Francis D Pagani; Antone J Tatooles; Geetha Bhat; Mark S Slaughter; Emma J Birks; Steven W Boyce; Samer S Najjar; Valluvan Jeevanandam; Allen S Anderson; Igor D Gregoric; Hari Mallidi; Katrin Leadley; Keith D Aaronson; O H Frazier; Carmelo A Milano
Journal:  N Engl J Med       Date:  2017-02-02       Impact factor: 91.245

3.  Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.

Authors:  Nir Uriel; Sang-Woo Pak; Ulrich P Jorde; Brigitte Jude; Sophie Susen; Andre Vincentelli; Pierre-Vladimir Ennezat; Sarah Cappleman; Yoshifumi Naka; Donna Mancini
Journal:  J Am Coll Cardiol       Date:  2010-07-02       Impact factor: 24.094

4.  Heart transplant vs left ventricular assist device in heart transplant-eligible patients.

Authors:  Matthew L Williams; Jaimin R Trivedi; Kelly C McCants; Sumanth D Prabhu; Emma J Birks; Laurie Oliver; Mark S Slaughter
Journal:  Ann Thorac Surg       Date:  2011-03-24       Impact factor: 4.330

5.  The cost of medical management in advanced heart failure during the final two years of life.

Authors:  Mark J Russo; Annetine C Gelijns; Lynne W Stevenson; Bhaven Sampat; Keith D Aaronson; Dale G Renlund; Deborah D Ascheim; Kimberly N Hong; Mehmet C Oz; Alan J Moskowitz; Eric A Rose; Leslie W Miller
Journal:  J Card Fail       Date:  2008-07-21       Impact factor: 5.712

6.  Readmissions after implantation of axial flow left ventricular assist device.

Authors:  Tal Hasin; Yariv Marmor; Walter Kremers; Yan Topilsky; Cathy J Severson; John A Schirger; Barry A Boilson; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Brooks S Edwards; Naveen L Pereira; John M Stulak; Lyle Joyce; Richard Daly; Soon J Park; Sudhir S Kushwaha
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

7.  Factors determining post-operative readmissions after left ventricular assist device implantation.

Authors:  Athanasios Tsiouris; Gaetano Paone; Hassan W Nemeh; Robert J Brewer; Jeffrey A Morgan
Journal:  J Heart Lung Transplant       Date:  2014-06-04       Impact factor: 10.247

8.  Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.

Authors:  Anna L Meyer; Doris Malehsa; Ulrich Budde; Christoph Bara; Axel Haverich; Martin Strueber
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

9.  Bias-corrected estimates for logistic regression models for complex surveys with application to the United States' Nationwide Inpatient Sample.

Authors:  Kevin A Rader; Stuart R Lipsitz; Garrett M Fitzmaurice; David P Harrington; Michael Parzen; Debajyoti Sinha
Journal:  Stat Methods Med Res       Date:  2015-08-11       Impact factor: 3.021

10.  Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival.

Authors:  Nicholas G Smedira; Katherine J Hoercher; Brian Lima; Maria M Mountis; Randall C Starling; Lucy Thuita; Darlene M Schmuhl; Eugene H Blackstone
Journal:  JACC Heart Fail       Date:  2013-02-04       Impact factor: 12.035

View more
  2 in total

1.  Center Variation in Medicare Spending for Durable Left Ventricular Assist Device Implant Hospitalizations.

Authors:  Michael P Thompson; Francis D Pagani; Qixing Liang; Lynze R Franko; Min Zhang; Jeffrey S McCullough; Raymond J Strobel; Keith D Aaronson; Robert L Kormos; Donald S Likosky
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

2.  Twelfth Interagency Registry for Mechanically Assisted Circulatory Support Report: Readmissions After Left Ventricular Assist Device.

Authors:  Palak Shah; Melana Yuzefpolskaya; Gavin W Hickey; Khadijah Breathett; Omar Wever-Pinzon; Van-Khue Ton; William Hiesinger; Devin Koehl; James K Kirklin; Ryan S Cantor; Jeffrey P Jacobs; Robert H Habib; Francis D Pagani; Daniel J Goldstein
Journal:  Ann Thorac Surg       Date:  2022-01-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.